The World Health Organization has concluded that the Democratic Republic of the Congo's 2026 Ebola outbreak was already spreading in February — at least three months before authorities formally declared it on 15 May. The finding, drawn from genetic sequencing of early virus samples, helps explain how an outbreak caused by Bundibugyo virus was able to establish itself across a wide swath of eastern and northern DRC before the international response began in earnest. As of 21 September, the outbreak had produced 7,773 confirmed cases and 3,759 confirmed deaths, a crude case-fatality ratio of about 48.3%, with transmission reported in 62 health zones across seven provinces. The country remains under a public health emergency of international concern, a determination made by WHO Director-General Tedros Adhanom Ghebreyesus on 17 May and still in force after the WHO Emergency Committee met on 18 August. The epidemic is not over, but the past three weeks have brought the first clear signs of slowing in two of the hardest-hit provinces.
A declaration that came months late
The gap between the start of transmission and the formal declaration is now the central fact of the outbreak's early history. Mohamed Janabi, the WHO's Regional Director for Africa, said on 10 August that genetic sequencing indicated the virus had begun spreading in February. That reconstruction, based on the virus's genetic clock rather than on clinical records alone, places the beginning of the outbreak well before any of the events that eventually triggered an international response.
The clinical timeline is more compressed but still predates the declaration. According to BBC reporting, the first known case identified in the investigation was a nurse who developed symptoms on 24 April. WHO and partner agencies were alerted to a high-mortality outbreak in Ituri Province on 5 May, according to the French National Research Agency's filovirus response unit. The pathogen was identified as Bundibugyo virus on 15 May — the same day the outbreak was officially declared.
Between those dates lies the reason the response has been so difficult. Early infections were reportedly misdiagnosed as malaria or typhoid, two illnesses that are endemic across much of the DRC and present with fever and other symptoms that overlap with early Ebola. That misdiagnosis delayed recognition of the outbreak and allowed transmission to continue undetected through health facilities and communities. By the time responders arrived, the chains of transmission had already extended beyond the initial area.
WHO officials have characterised the event as the fastest-growing Ebola outbreak on record, a description that has circulated widely in reporting on the epidemic. It is worth treating that characterisation as an assessment offered by officials and reported by media, rather than as a comparative ranking that has been independently verified against the historical record of previous outbreaks.
Where the outbreak stands now
The consolidated figures available as of 25 September describe an epidemic that is geographically expanding, with sustained transmission and a high mortality rate, even as it shows localised improvement. The WHO counts 7,773 confirmed cases and 3,759 confirmed deaths in the DRC. The crude case-fatality ratio derived from those two totals is approximately 48.3% — a figure that reflects the deadliness of Bundibugyo virus in this setting and the difficulty of delivering supportive care in the affected regions.
Transmission has been reported in 62 health zones across seven provinces: Ituri, North Kivu, South Kivu, South Ubangi, Haut-Uele, Bas-Uele and Tshopo. That footprint matters. The outbreak began in Ituri, which continues to carry the greatest burden, and later reached six additional provinces, including areas that border or lie near neighbouring states. Reaching that many provinces means the response must be conducted across multiple health systems, languages and transport corridors, some of them in areas with limited road access and a history of conflict.
The WHO has also reported involvement beyond the DRC's borders. Uganda has been affected, with one related case reported in France and two DRC-diagnosed patients subsequently treated in Germany, according to the agency's 26 August international update. Those movements are a reminder that in a globally connected world, an outbreak in one province of one country is never purely a local affair — though the detection of a small number of exported cases does not, on the evidence available, indicate widespread transmission outside the region.
Why the February start date matters
Genomic sequencing has become one of the most important tools in outbreak investigation because it allows scientists to reconstruct when a virus began circulating, even when the clinical record is incomplete. By comparing genetic differences between samples taken from different patients, researchers can estimate how long the virus has been spreading and roughly how many generations of transmission have occurred. Janabi's public explanation of the February start date was built on precisely this kind of analysis.
The practical consequences of a three-month head start are significant. An outbreak that begins in February and is recognised in May has had roughly a dozen weeks to move through communities, health centres and households before any surveillance system was specifically looking for it. Vaccination campaigns, contact tracing, isolation capacity and safe burial practices — the core interventions that interrupt Ebola transmission — all begin from the moment of recognition, not from the moment of first infection. Every week of undetected spread is a week in which those interventions are not operating.
Health officials have not suggested that the delay was the result of negligence by any particular actor. The more accurate reading, based on the available information, is that the overlap between early Ebola symptoms and common endemic diseases created a diagnostic blind spot in a region where malaria and typhoid are routinely encountered and where laboratory confirmation for haemorrhagic fevers is not universally available at the point of care. The misdiagnoses that delayed recognition were, in that sense, a systems problem rather than an individual failure.
The response on the ground
The WHO country and regional teams are supporting surveillance, laboratory confirmation, case management, infection prevention and control, vaccination-related operations, risk communication and cross-border coordination, according to the agency. The DRC's national and provincial health authorities are leading the domestic response, working alongside WHO and international partners.
Bundibugyo virus presents particular challenges for the response. It is one of the Ebola viruses, but it is distinct from the Zaire ebolavirus that has been responsible for most of the large outbreaks of the past decade and for which licensed vaccines and therapeutics were developed and deployed at scale. The research material reviewed does not specify which vaccine or therapeutic products are in use in this outbreak or what proportion of contacts have been vaccinated, and those figures should not be assumed.
The geography of the response is another constraint. Ituri, where the outbreak began and where the burden is greatest, has a long history of armed conflict and displacement, both of which complicate contact tracing and community engagement. The seven affected provinces span a large area of the country, requiring the response to operate simultaneously in multiple settings with different epidemiological profiles — some with dense transmission, others with sporadic cases.
Tentative signs of improvement
There are indications that the response is beginning to have an effect in at least some areas. During the 21 days preceding the United Nations' 23 September update, reported cases fell by approximately 26% in Ituri and 15% in Haut-Uele. Those are meaningful declines in two significant provinces, and they suggest that the combination of surveillance, isolation and community-level measures is reducing transmission where it is being applied most intensively.
They are not, however, evidence that the outbreak is ending. The overall national total continued to rise over the same period, and the outbreak remained active in multiple provinces. A decline in reported cases can also reflect reporting dynamics — a reduction in the number of health zones able to submit data, for example, or a change in testing patterns — and it is not possible from the available information to determine how much of the improvement reflects genuine epidemiological change. The WHO's own characterisation of the epidemic as geographically expanding, with sustained transmission, is a caution against reading the provincial declines as the beginning of the end.
The emergency declaration and what it does
Tedros determined on 17 May, two days after the outbreak was declared, that it constituted a public health emergency of international concern. That is the WHO's highest level of alarm under the International Health Regulations. The designation obliges member states to take specific measures, provides the legal and political basis for international coordination, and signals to donors and governments that the event warrants sustained attention and resources. The decision remained in force following the Emergency Committee's meeting on 18 August.
The declaration has not, on its own, resolved the operational problems that made the outbreak's early weeks so costly. Emergency declarations can unlock funding and attention; they cannot retroactively shorten a transmission chain that had been growing for three months. That asymmetry between the speed of a virus and the speed of institutional recognition is one of the recurring lessons of recent outbreak history, and the February-to-May gap documented here is a particularly stark illustration of it.
Different perspectives on the delay
The finding that the virus circulated for months before detection has drawn attention to the state of early-warning surveillance in the affected provinces. The available research does not include extensive on-the-record commentary from Congolese officials, independent epidemiologists or community representatives about the delay, and the reports do not identify a single current DRC official as the public face of the response. That absence is itself notable: a national response of this scale typically acquires identifiable spokespeople, and the lack of one in the material reviewed suggests that public communication has been handled at the institutional rather than individual level.
What can be said on the basis of the available information is that the WHO's own framing emphasises the role of sequencing in uncovering the earlier start, and that officials have presented the February date as an explanatory finding rather than as a retrospective criticism of any authority. The characterisation of the outbreak as the fastest-growing on record carries an implicit acknowledgement that the early response was outpaced by the pathogen.
There is also a countervailing perspective to consider. The DRC has extensive experience with Ebola, having responded to multiple outbreaks over the past decade, and the detection of a high-mortality cluster in Ituri on 5 May and the identification of Bundibugyo virus on 15 May indicate that once the signal was received, the diagnostic and reporting chain moved promptly. The delay occurred upstream of that system — in the clinics and communities where the first cases were seen and misattributed to more common diseases.
What happens next
Three questions will shape the trajectory of the outbreak over the coming weeks and months.
The first is whether the declines in Ituri and Haut-Uele translate into a sustained national reduction. A 21-day window is a short period on which to base a trend, and the national total rose over the same interval. If transmission is genuinely falling in the two provinces that have carried the largest burden, that would be a significant development; if the decline reflects reporting or testing artefacts, the outbreak could continue on its current path.
The second is whether the outbreak remains confined to the seven provinces where it has already been reported. The involvement of Uganda and the small number of cases detected in France and Germany demonstrate that the virus can travel. Cross-border coordination is explicitly part of the WHO's described support activities, and the coming weeks will indicate whether that coordination is holding.
The third is how long the public health emergency of international concern remains in place. That decision rests with Tedros, on the advice of the Emergency Committee. The committee last met on 18 August and the determination was still in force afterwards. A renewed assessment would signal either continued concern or a shift toward the later stages of the response.
For now, the picture is of an outbreak that has killed thousands, spread across more than 60 health zones, and acquired a three-month head start that no amount of subsequent effort can recover. The documented improvement in parts of eastern DRC is real and worth noting — but with 7,773 confirmed cases, 3,759 confirmed deaths and a case-fatality ratio near 48%, the epidemic remains one of the gravest health emergencies in the world, and its end is not yet in sight.